Skip to main content
Top

Drugs

Issue 1/2023

Content (7 Articles)

Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?

Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, Francois Philippart

TKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors

Homma M. Khosroyani, Lillian R. Klug, Michael C. Heinrich

An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers

  • Original Research Article

Lu Chen, Elke H. J. Krekels, Anne R. Heijnen, Catherijne A. J. Knibbe, Roger J. Brüggemann

Ozoralizumab: First Approval

Susan J. Keam

Tremelimumab: First Approval

  • NSCLC
  • Adisinsight Report

Susan J. Keam

Correction to: Spesolimab: First Approval

  • Open Access
  • Correction

Hannah A. Blair

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images